Kinins in pain and inflammation
Top Cited Papers
- 1 July 2000
- journal article
- review article
- Published by Wolters Kluwer Health in PAIN®
- Vol. 87 (1) , 1-5
- https://doi.org/10.1016/s0304-3959(00)00335-3
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Bradyzide, a potent non‐peptide B2 bradykinin receptor antagonist with long‐lasting oral activity in animal models of inflammatory hyperalgesiaBritish Journal of Pharmacology, 2000
- In vivo B1 kinin‐receptor upregulation. Evidence for involvement of protein kinases and nuclear factor κB pathwaysBritish Journal of Pharmacology, 1999
- Requirement of Phosphatidylinositol 3-Kinase Activity for Bradykinin Stimulation of NF-κB Activation in Cultured Human Epithelial CellsPublished by Elsevier ,1999
- Bradykinin stimulates interleukin‐8 production by human lung fibroblastsImmunology, 1998
- The nonpeptide B2receptor antagonist FR173657: inhibition of effects of bradykinin related to its role in nociceptionBritish Journal of Pharmacology, 1998
- The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts.Journal of Clinical Investigation, 1998
- Transcription Factor Nuclear Factor κB Regulates the Inducible Expression of the Human B1 Receptor Gene in InflammationPublished by Elsevier ,1998
- BRADYKININ SYNERGISTICALLY STIMULATES INTERLEUKIN 6 PRODUCTION IN HUMAN GINGIVAL FIBROBLASTS CHALLENGED WITH INTERLEUKIN 1 OR TUMOUR NECROSIS FACTOR αCytokine, 1998
- Effects of a nonpeptide bradykinin B2receptor antagonist, FR167344, on differentin vivoanimal models of inflammationBritish Journal of Pharmacology, 1997
- Characterization of FR173657, a novel nonpeptide B2antagonist: in vitro and in vivo studiesCanadian Journal of Physiology and Pharmacology, 1997